BLING III: A phase III randomised controlled trial of continuous beta-lactam infusion compared with intermittent beta-lactam dosing in critically ill patients

Critical Care Research, Translation and Training Lead

CRE RESPOND

Emeritus Professor

Frazer Institute

Director

CRE RESPOND

Deputy Director

Frazer Institute

NHMRC Leadership Fellow

The University of Queensland

Pharmacist Consultant

Royal Brisbane & Women’s Hospital

European Collaboration Co-Lead

CRE RESPOND

ICU Physician and Chair of AZUREA Research

University of Nîmes

Infectious Diseases Research and Translation Lead

CRE RESPOND

NHMRC Leadership Fellow and Infectious Diseases Physician and Director

Frazer Institute

European Collaboration Co-Lead

CRE RESPOND

Critical Care Physician

Ghent University Hospital

Clinical dosing studies workstream lead

CRE RESPOND

Postdoctoral Research Fellow

Frazer Institute

Project members